Showing results (661-670 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|February 1, 1989
Subjective profile of phenylpropanolamine: absence of stimulant or euphorigenic effects at recommended dose levelsJ P Morgan, F R Funderburk, G L Blackburn, et al.Journal of Clinical Psychopharmacology|June 1, 1989
Anticholinergic effects on memory: benztropine versus amantadineA J Gelenberg, T Van Putten, P W Lavori, et al.Journal of Clinical Psychopharmacology|April 1, 1989
Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxietyG D Tollefson, M Godes, J Montague-Clouse, et al.Journal of Clinical Psychopharmacology|June 9, 2016
Safety of Intravenous Methamphetamine Administration During Ibudilast TreatmentDustin Z DeYoung, Keith G Heinzerling, Aimee-Noelle Swanson, et al.Journal of Clinical Psychopharmacology|August 14, 2014
Risperidone-associated urinary incontinence in patients with autistic disorder with mental retardationHirokazu Kumazaki, Koichiro Watanabe, Yasushi Imasaka, et al.Journal of Clinical Psychopharmacology|August 14, 2014
Reboxetine adjuvant therapy in patients with schizophrenia showing a suboptimal response to clozapine: a 12-week, open-label, pilot studyAntonio Bruno, Rocco Zoccali, Paolo Micali Bellinghieri, et al.Journal of Clinical Psychopharmacology|November 26, 2014
A randomized, double-blind, placebo-controlled phase 2 study of the augmentation of a nicotinic acetylcholine receptor partial agonist in depression: is there a relationship to leptin levels?Maurizio Fava, Tanya Ramey, Eve Pickering, et al.Journal of Clinical Psychopharmacology|June 17, 2016
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic ReviewSaínza García, Mónica Martínez-Cengotitabengoa, Saioa López-Zurbano, et al.Journal of Clinical Psychopharmacology|June 1, 1989
The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitorsD Kahn, J M Silver, L A OplerJournal of Clinical Psychopharmacology|February 13, 2016
Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum DisordersChonlaphat Sukasem, Yaowaluck Hongkaew, Nattawat Ngamsamut, et al.Pageof 332